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Abstract A cell-free protein expression system was established
that provides protein samples of adequate concentration and
purity for direct NMR analysis. The Escherichia coli peptid-
yl^prolyl cis^trans isomerase PpiB was expressed in this system
with dual amino acid-selective isotope labeling to identify the
NMR signal from the active site-residue Arg87. Addition of the
substrate succinyl-Ala-Ala-Pro-Phe-p-nitroanilide selectively
shifted its 15N-HSQC cross peak, con¢rming binding to the
active site. As cell-free protein expression provides high yields
of protein per unit mass of labeled amino acid and sample han-
dling is minimal, this strategy presents an exceptionally inex-
pensive and rapid approach to protein analysis. - 2002 Fed-
eration of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
NMR spectroscopy is an important tool for the identi¢ca-
tion of protein^ligand interactions. Often, the 15N-HSQC
spectrum of a sample of 15N labeled protein is used to mon-
itor ligand binding. Since every backbone amide group is rep-
resented by a cross peak in the 15N-HSQC spectrum, chemical
shift changes or the disappearance of signals observed upon
addition of the ligand provide site-speci¢c information about
ligand binding [1]. With prior knowledge about potential
binding sites, the 15N-HSQC cross peaks of strategically chos-
en amino acids can be identi¢ed by a dual amino acid-selec-
tive labeling technique to avoid assignment of the entire 15N-
HSQC spectrum [2^4]. A major drawback of the selective
labeling strategy for proteins expressed in vivo is the time-
consuming puri¢cation of every selectively labeled sample
and the higher cost of labeled amino acids versus the ammo-
nium salts used for uniform labeling with 15N. Various strat-
egies to increase e⁄ciency of such experiments have focused
on recording 15N-HSQC spectra of partially puri¢ed proteins
or even in situ in whole Escherichia coli cells [5^10]. Particu-
larly clean spectra have been obtained by the use of auxotro-
phic bacterial strains for expression [11]. However, in-cell
NMR results in broad signals due to high intracellular viscos-
ity, while cell lysis exposes the protein to temperature and
chemical stress, including exposure to cell debris and proteo-
lytic enzymes.
An attractive alternative is presented by use of a cell-free in
vitro protein expression system, which can produce high yields
of protein per input mass of labeled amino acid without the
need for use of auxotrophic bacterial strains [4,12^14]. Here
we show that cell-free protein expression produces selectively
labeled proteins in adequate yield and of high purity so that,
when combined with the sensitivity of a cryoprobe, 15N-
HSQC spectra can be recorded directly without further puri-
¢cation or concentration. This opens the door to high-
throughput ligand-binding studies by NMR spectroscopy,
where the number of sample handling steps is drastically mini-
mized and parallel sample preparation is readily amenable to
automation.
2. Materials and methods
Two E. coli proteins were expressed, cytoplasmic peptidyl^prolyl
cis^trans isomerase (PpiB) and aspartyl-tRNA synthetase (AspRS),
using modi¢cations of the cell-free expression procedure of Kigawa
et al. [14]. Supercoiled plasmids pKE874 [15] and pPL830 (P.E. Lilley
and N.E.D., unpublished) were used as DNA templates for in vitro
expression of PpiB and AspRS, respectively. These plasmids contain
the E. coli ppiB and aspS genes inserted so that they are transcribed
from tandem bacteriophage V pR and pL promoters [16]. Unlabeled
PpiB was puri¢ed as described [15]. Its concentration was determined
spectrophotometrically using a molecular weight of 18 154 and an O280
value of 9 530 M31 cm31 [17]. E. coli RNA polymerase was puri¢ed
from cells of strain C600 as described by Burgess et al. [18] and
separated into holoenzyme and core fractions as described by Gonza-
lez et al. [19].
The S-30 extract used for the cell-free protein synthesis was pre-
pared from E. coli strain A19 [20] (metB rna ; CGSC No. 5997), as
described [21]. The S-135 extract and a crude ribosomal fraction were
prepared from the S-30 extract according to Patnaik and Swartz
[22], and Kudlicki et al. [23], respectively. [U-15N]L-arginine and
[1-13C]L-alanine were gifts of Cambridge Isotope Laboratories (An-
dover, MA, USA).
Inner-chamber reaction mixtures (0.3 ml each) contained HEPES^
KOH (55 mM, pH 7.5), dithiothreitol (1.7 mM), ATP (1.2 mM), CTP,
GTP and UTP (0.8 mM each), 3P,5P-cyclic AMP (0.64 mM), folinic
acid (68 WM), ammonium acetate (27.5 mM), potassium glutamate
(208 mM), creatine phosphate (80 mM), creatine kinase (Roche;
250 Wg/ml), twenty L-amino acids (1 mM each), magnesium acetate
(15 mM), E. coli total tRNA (Roche; 175 Wg/ml), NaN3 (0.05%, w/v),
S-135 extract (48 Wl), ribosome fraction (24 Wl), supercoiled plasmid
DNA (16 Wg/ml for PpiB; 14 Wg/ml for AspRS), RNase inhibitor
(Promega; 150 U), and RNA polymerase holoenzyme (0.155 mg/
ml). When used, PEG-8000 was added to 2% (w/v). The inner-cham-
ber reaction mixtures were dialyzed in Spectrapor 2 tubing (12^14 kDa
0014-5793 / 02 / $22.00 K 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 3 0 4 8 - X
*Corresponding author. Fax: (61)-2-6125 0750.
E-mail address: dixon@rsc.anu.edu.au (N.E. Dixon).
FEBS 26323 19-7-02
FEBS 26323 FEBS Letters 524 (2002) 159^162
cuto¡; Spectrum Laboratories), for 12 h at 37‡C with shaking at
180 rpm against outer-chamber solution (6 ml; changed after 3 and
6 h) contained in a test tube. The outer-chamber solution had the
same composition as the inner-chamber reaction mixture, except
that S-135 extract, ribosomal fraction, tRNA, plasmid DNA, RNA
polymerase, creatine kinase and RNase inhibitor were omitted, and
the concentration of magnesium acetate was raised to 19.3 mM. Prior
to analysis by sodium dodecyl sulfate (SDS)^polyacrylamide (15%) gel
electrophoresis, proteins in samples were precipitated with ¢ve vol-
umes of ice-cold acetone, collected by centrifugation, resuspended in a
gel loading mixture containing 2% (w/v) SDS, and heated for 2 min at
90‡C.
For preparation of samples of 15N-Arg/13C-Ala labeled PpiB, the
labeled amino acids (1 mM each) replaced unlabeled L-Ala and L-Arg
in both mixtures. NMR measurements were carried out after combin-
ing two identical 0.3 ml reaction mixtures, followed by their ultra-
centrifugation (100 000U g, 4 h) and addition of 10% D2O to provide
a lock signal. All NMR spectra were recorded at 25‡C, pH 7, on a
Bruker DMX-600 NMR spectrometer equipped with a triple-reso-
nance (1H, 15N, 13C) cryoprobe with single-axis pulsed ¢eld gradients,
using a conventional 5 mm sample tube.
3. Results and discussion
The reaction conditions were similar to those established by
Kigawa et al. [14] with a few notable exceptions, including
transcription driven by E. coli RNA polymerase from tandem
bacteriophage V pR and pL promoters in the supercoiled plas-
mid template DNA, rather than by phage T7 RNA polymer-
ase from a T7 promoter. Furthermore, the extract was sup-
plemented by a crude ribosomal fraction, rather than being
preconcentrated, and additional puri¢ed E. coli RNA poly-
merase holoenzyme was added to boost expression yields.
Finally, our system allowed the omission of polyethylene gly-
col (see below).
For two proteins expressed in this way, PpiB and AspRS,
straightforward ultracentrifugation provided e⁄cient puri¢ca-
tion, rendering both PpiB and AspRS as the predominant
proteins in solution (Fig. 1A). Expression yields of s 1 mg
of PpiB per ml of reaction volume were achieved (Fig. 1B).
A solution of 15N-Arg/13C-Ala labeled PpiB thus prepared
was used to identify the cross peak of Arg87 by the
1J(15N,13C) coupling between Arg87 and Ala86. PpiB contains
¢ve arginyl residues, of which only Arg87 is preceded by an
alanyl residue. The 15N-HSQC spectrum in Fig. 2A shows the
cross peaks of all ¢ve arginyl residues in 15N-Arg/13C-Ala
labeled PpiB. Recording of the ¢rst 15N^1H plane of an
HNCO experiment [24] resulted in a 15N-HSQC-type spec-
trum, containing only the cross peak of Arg87 (Fig. 2B).
Addition of the PpiB substrate succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide (suc-AAPF-pNA, purchased from Bachem, Swit-
zerland) to 5 mM shifted and broadened the cross peak of
Arg87, indicating a high population of the enzyme^substrate
complex (Fig. 2C). This is as predicted from the KM values of
ca. 1 mM measured for the related proteins, bovine and hu-
man cyclophilin, with the same substrate [25]. (To the best of
our knowledge, KM values have not been measured for PpiB.)
In contrast, the presence of 6 mM succinyl-Ala-Pro-Ala did
not change the 15N-HSQC spectrum (data not shown), in spite
of the complex of PpiB with succinyl-Ala-Pro-Ala-pNA being
su⁄ciently stable for crystallization [26]. This suggests that the
Fig. 1. In vitro expression of PpiB (18 kDa) and aspartyl-tRNA synthetase (AspRS, 66 kDa). Reactions were carried out for 12 h using a dial-
ysis system, and products were separated by SDS^polyacrylamide (15%) gel electrophoresis. A: Expressed proteins are soluble and reaction
mixtures can be puri¢ed by ultracentrifugation. Reaction mixtures contained 2% (w/v) PEG-8000. Lanes 1^3: PpiB; lanes 4^6: AspRS. Lanes 1
and 4: crude inner-chamber reaction mixtures; lanes 2 and 5, supernatants after ultracentrifugation (PpiB and AspRS give the strongest
bands); lanes 3 and 6: pellets after ultracentrifugation (PpiB and AspRS are virtually absent). B: Expression of PpiB is una¡ected by omission
of PEG-8000. Supernatants after ultracentrifugation of crude inner-chamber mixtures from reactions carried out in the presence (lane 1) or ab-
sence (lane 2) of PEG-8000 (2% w/v). These were the samples of 13C-Ala/15N-Arg labeled PpiB used for NMR experiments (Fig. 2). Lanes 3, 4
and 5 from the same gel contained amounts of puri¢ed PpiB corresponding to ¢nal concentrations in the reaction mixtures of 0.8, 1.0 and
1.2 mg/ml, respectively. Mobilities of molecular weight markers were as indicated. The gels were stained with Coomassie Blue.
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aromatic groups in this substrate, as well as in suc-AAPF-
pNA, signi¢cantly stabilize the respective complexes with
PpiB.
The high quality of the 15N-HSQC spectra is remarkable, as
a conventional one-dimensional 1H NMR spectrum of the
reaction mixture was completely dominated by the signals
from bu¡er and amino acid components. Clearly, only the
product protein was e⁄ciently enriched with 15N-Arg and
13C-Ala. As expected, no cross peak was observed for any
excess 15N-amino acid, since the signals from K-amino groups
are broadened beyond detection by exchange with water pro-
tons. However, the E. coli extracts do contain enzymes that
transform a fraction of the amino acids into low-molecular-
weight metabolites, in which their K-amino groups are deriv-
atized to amides. These compounds give rise to prominent
signals in the 15N-HSQC spectra and were also observed in
NMR spectra recorded of whole E. coli cells [10]. For exam-
ple, the spectra in Fig. 2A,C contained a cross peak of narrow
linewidth at 131.7 ppm (15N)/7.87 ppm (1H) (not shown).
Although ultra¢ltration readily separated the corresponding
compound from PpiB, no ultra¢ltration was carried out be-
fore recording the spectra shown in Fig. 2.
The cell-free expression system reported by Kigawa et al.
[14] includes 4% PEG-8000 to achieve a concentration (ex-
cluded volume) e¡ect. In the case of PpiB expressed with
our cell-free system, however, very similar protein yields
were obtained with and without PEG (Fig. 1B). The increased
viscosity caused by 2% PEG resulted in less than 5 Hz line-
broadening in the 1H dimension of the 15N-HSQC spectra.
4. Conclusions
Cell-free protein expression combined with the sensitivity of
a cryoprobe enables an inexpensive high-throughput strategy
for protein analysis : selectively labeled proteins can be ex-
pressed in 0.5 ml of reaction medium using small quantities
of labeled amino acids (6.5 mg of 15N-Arg and 2.8 mg of
13C-Ala in the present case) and the samples can be analyzed
by NMR and studied for ligand binding at the concentration
of the reaction medium without any chromatographic puri¢-
cation and with minimal sample handling. All steps from ex-
pression to the ready NMR spectra can be completed in less
than 24 h. Except for the broadened signal of Arg87, all cross
peaks of Fig. 2C were already observable in a spectrum re-
corded in 2 h. Many samples could easily be prepared in
parallel. Analysis of several selectively labeled samples is par-
ticularly attractive for large proteins, where uniform labeling
would result in severe signal overlap and MUSIC-type resi-
due-selective pulse sequences would fail due to sensitivity
problems [27,28]. Notably, there is already su⁄cient signal
overlap in the 15N-HSQC spectrum of uniformly labeled
PpiB that the resonance of Arg87 is incompletely resolved,
and it would not be trivial to attribute spectral changes in-
duced by the substrate to speci¢c residues [29].
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